Current Concepts on the Molecular Pathology of Non-small Cell Lung Carcinoma

Por Fujimoto, Junya, Wistuba, Ignacio I.
Publicado em 2014

The evolving genomic classification of lung cancer

Por Shames, David S, Wistuba, Ignacio I
Publicado no J Pathol (2014)

Lung Cancer Biomarkers

Por Villalobos, Pamela, Wistuba, Ignacio I.
Publicado no Hematol Oncol Clin North Am (2017)

Field Cancerization in Non–Small Cell Lung Cancer: Implications in Disease Pathogenesis

Por Kadara, Humam, Wistuba, Ignacio I.
Publicado no Proc Am Thorac Soc (2012)

Pulmonary adenocarcinoma: A renewed entity in 2011

Por Kadara, Humam, Kabbout, Mohamed, Wistuba, Ignacio I.
Publicado em 2012

Germ-Line and Somatic Presentations of the EGFR T790M Mutation in Lung Cancer

Por Prudkin, Ludmila, Tang, Ximing, Wistuba, Ignacio I.
Publicado no J Thorac Oncol (2009)

New Strategies in Squamous Cell Carcinoma of the Lung: Identification of Tumor Drivers to Personalize Therapy

Por Gold, Kathryn A., Wistuba, Ignacio I., Kim, Edward S.
Publicado em 2012

Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non–small cell lung cancer

Por Shien, Kazuhiko, Papadimitrakopoulou, Vassiliki A., Wistuba, Ignacio I.
Publicado no Lung Cancer (2016)

Exponential Decay Nonlinear Regression Analysis of Patient Survival Curves: Preliminary Assessment in Non-Small Cell Lung Cancer

Por Stewart, David J., Behrens, Carmen, Roth, Jack, Wistuba, Ignacio I.
Publicado em 2011

Squamous cell carcinoma – similarities and differences among anatomical sites

Por Yan, Wusheng, Wistuba, Ignacio I, Emmert-Buck, Michael R, Erickson, Heidi S
Publicado em 2010

Personalizing Lung Cancer Prevention Through a Reverse Migration Strategy

Por Gold, Kathryn A., Kim, Edward S., Wistuba, Ignacio I., Hong, Waun K.
Publicado em 2013

Fragile Histidine Triad Gene Abnormalities in the Pathogenesis of Gallbladder Carcinoma

Por Wistuba, Ignacio I., Ashfaq, Raheela, Maitra, Anirban, Alvarez, Hector, Riquelme, Erick, Gazdar, Adi F.
Publicado em 2002

LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells

Por Maki, Yuho, Fujimoto, Junya, Lang, Wenhua, Xu, Li, Behrens, Carmen, Wistuba, Ignacio I., Kadara, Humam
Publicado no Sci Rep (2015)

DeMix: deconvolution for mixed cancer transcriptomes using raw measured data

Por Ahn, Jaeil, Yuan, Ying, Parmigiani, Giovanni, Suraokar, Milind B., Diao, Lixia, Wistuba, Ignacio I., Wang, Wenyi
Publicado em 2013

The BATTLE to Personalize Lung Cancer Prevention through Reverse Migration

Por Gold, Kathryn A., Kim, Edward S., Lee, J. Jack, Wistuba, Ignacio I., Farhangfar, Carol J., Hong, Waun Ki
Publicado em 2011

EGFR Abnormalities in the Pathogenesis and Progression of Lung Adenocarcinomas

Por Tang, Ximing, Varella-Garcia, Marileila, Xavier, Ana Carolina, Massarelli, Erminia, Ozburn, Natalie, Moran, Cesar, Wistuba, Ignacio I.
Publicado em 2008

Integrating whole transcriptome sequence data and public databases for analysis of somatic mutations in tumors

Por Momin, Amin A, James, Brian P, Motter, Thomas C, Kadara, Humam N, Powis, Garth, Wistuba, Ignacio I
Publicado em 2011

Nuclear Receptor Expression Defines a Set of Prognostic Biomarkers for Lung Cancer

Por Jeong, Yangsik, Xie, Yang, Xiao, Guanghua, Behrens, Carmen, Girard, Luc, Wistuba, Ignacio I., Minna, John D., Mangelsdorf, David J.
Publicado em 2010

Expression of insulin-like growth factor I receptor as a biomarker for predicting prognosis in biliary tract cancer patients

Por SUZUKI, HIDEO, ROA, JUAN C., KAWAMOTO, TORU, ISHIGE, KAZUNORI, WISTUBA, IGNACIO I., LI, DONGHUI, THOMAS, MELANIE B., SHODA, JUNICHI
Publicado no Mol Clin Oncol (2015)

Immunohistochemical Expression of Basic Fibroblast Growth Factor and Fibroblast Growth Factor Receptors 1 and 2 in the Pathogenesis of Lung Cancer

Por Behrens, Carmen, Lin, Heather Y., Lee, J. Jack, Raso, Maria Gabriela, Hong, Waun Ki, Wistuba, Ignacio I., Lotan, Reuben
Publicado no Clin Cancer Res (2008)